M. Schroeder

发表

Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie

T. Gauler, A. Dietz, D. Arnold, 2013, Oncology.

Ifosfamide (IFO)+vinorelbine (VRL) as treatment for advanced, non operable non small cell lung cancer (NSCLC)

S. Kerpel-Fronius, J. Pawel, P. Tresca, 1994 .

Cyclic Alternating versus Response-Orientated Alternating Chemotherapy in Small Cell Lung Cancer1

R. Holle, H. Flechtner, H. Becker, 1989 .

Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108).

Harry W. Lindeman, T. Gauler, A. Dietz, 2019, European journal of cancer.

Experience of a German multicenter study group with ifosfamide in small cell lung cancer.

R. Holle, H. Flechtner, H. Becker, 1989, Seminars in oncology.

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

A. Dietz, M. Flentje, H. Eckel, 2001, International journal of radiation oncology, biology, physics.

From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?

S. Joshi, H. Gabius, S. Gabius, 1994, Planta medica.

Distinct Gene Expression Pattern of Malignant Hematopoietic Stem and Progenitor Cells in Polycythemia Vera

C. Steidl, U. Steidl, G. Kobbe, 2005, Annals of the New York Academy of Sciences.

Topotecan/Cisplatin Compared with Cisplatin/Etoposide as First-Line Treatment for Patients with Extensive Disease Small-Cell Lung Cancer: Final Results of a Randomized Phase III Trial

J. Virchow, R. Huber, T. Ittel, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Multicenter randomized trial for stage IIIB/IV non-small-cell lung cancer using every-3-week versus weekly paclitaxel/carboplatin.

Michael Schroeder, Christian Schumann, C. Schumann, 2006, Clinical lung cancer.

Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer

U. Vanhoefer, S. Seeber, M. Stuschke, 2004, Journal of Cancer Research and Clinical Oncology.

Alternating versus sequential chemotherapy in small cell lung cancer. A randomized german multicenter trial

R. Holle, G. Bepler, K. Pflüger, 1987, Cancer.

Sequential methotrexate and 5-FU in breast cancer resistant to the conventional application of these drugs.

R. Herrmann, C. Manegold, D. Fritze, 1984, Cancer treatment reports.

[Anti-angiogenic therapy of a renal angiomyolipoma in a seriously disabled patient suffering from multiple sclerosis].

C. Aul, M. Schroeder, 2005, Aktuelle Urologie.

Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.

H. Flechtner, H. Becker, M. Pritsch, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.

R. Holle, K. Havemann, M. Wolf, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two randomized trials for alternating polychemotherapy of small cell lung cancer

R. Holle, K. Havemann, M. Heim, 2004, Cancer Chemotherapy and Pharmacology.

Chemotherapy for Adult Acute Myeloid Leukemia: Study Results from the Acute Myeloid Leukemia Cooperative Group and Overview

K. Straif, W. Siegert, E. Thiel, 1993 .

Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias.

U. Germing, J. Neukirchen, R. Haas, 2014, Leukemia research.

Results of Ifosfamide Combination Chemotherapy in Patients with Advanced Soft Tissue Sarcomas

M. Westerhausen, R. Fuchs, M. Schroeder, 1987 .

Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.

H. Eich, R. Semrau, A. Dietz, 2006, International journal of radiation oncology, biology, physics.

[Medicinal therapy of malignant lymphomas].

C. Aul, A. Giagounidis, M. Schroeder, 2002, Der Radiologe.

Familial malignant lymphoma — Duncan's syndrome

R. Becher, D. Neumann-Haefelin, M. Westerhausen, 1986, Journal of Cancer Research and Clinical Oncology.

Antibiotic Prophylaxis with Gyrase Inhibitors during Cytostatically Induced Granulocytopenias in Patients with Solid Tumors: A Double-Blind Prospective Randomized Study

M. Westerhausen, J. Selbach, C. Schadeck-Gressel, 1992 .

Alternating versus sequential chemotherapy in small cell lung cancer. A randomized german multicenter trial

R. Holle, G. Bepler, K. Pflüger, 1987, Cancer.

Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies.

K. Pfizenmaier, H. Bartsch, G. Nagel, 1989, European journal of cancer & clinical oncology.

Clinical Experience with Pirarubicin in the Treatment of Patients with Pretreated Head and Neck Cancer

M. Westerhausen, R. Donhuijsen-Ant, M. Schroeder, 1989 .

Innovations: Randomized phase II trial of erlotinib (E)/bevacizumab (B) compared with cisplatin (P)/gemcitabine (G) plus B in first-line treatment of advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).

A. Reuss, C. Kortsik, M. Eiff, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.